? CLINICAL RESEARCH DESIGN, EPIDEMIOLOGY AND BIOSTATISTICS CORE Use of robust study design with modern statistical and epidemiologic methods plays an essential role in integrated, multidisciplinary research teams created to optimize the pathway from the development of new treatments, techniques and devices in the laboratory to their application for improved diagnosis, treatment, and prevention of disease of patients. We propose to develop the Clinical Research Design, Epidemiology, and Biostatistics Key Component of the RI-CCTS to provide expertise and resources to facilitate research across institutional boundaries that will increase the capacity, sophistication, and application of contemporary analytical approaches to transform clinical and translational research in Rhode Island. The Key Component will connect strong but isolated research units scattered throughout Brown University Alpert Medical School and its seven affiliated hospitals, Brown School of Public Health and University of Rhode Island College of Pharmacy. Current collaboration among these entities has relied on ad hoc analytic teams that do not interface and study design mentoring with no unified core. As a result, methods expertise has failed to reach a broad clinical audience, existing teams have not benefited from others' experience and new methods and tools are not widely distributed.
We aim to create a central ?storefront? through which investigators could access all of the research tools available throughout the state and research training from its renowned academic affiliates. In order to develop this program, we propose the following three Specific Aims:
Specific Aim 1 : Services & Resources: Develop an easily accessible multidisciplinary, integrated center that provides support to clinical and translational investigators in study design as well as collection, management, analysis, interpretation and presentation of data using procedures that ensure quality control and reproducibility of all analyses Specific Aim 2: Education &

Mentoring

Develop and offer training materials in study design, epidemiology and biostatistics for early and mid-career investigators as well as provide training in statistical collaboration and consultation for core statistical staff and student consultants Specific Aim 3: Tools & Method Development: Provide a supportive environment to enable clinical investigators and statistical analysts to develop, validate and disseminate innovative design and analytical methodology arising from clinical and translational research problems The proposed Key Component will transform clinical and translational research in Rhode Island by creating universal access to critical expertise, tools and resources. This access will reach young investigators receiving Pilot Awards and clinicians in isolated environments. It will train young methodologists in research collaboration and provide young and old with a wider range of problems on which to develop and test innovative solutions.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54GM115677-05
Application #
9957177
Study Section
Special Emphasis Panel (ZGM1)
Project Start
Project End
Budget Start
2020-05-01
Budget End
2021-04-30
Support Year
5
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Brown University
Department
Type
DUNS #
001785542
City
Providence
State
RI
Country
United States
Zip Code
02912
Pereira, Jorge; Renzulli 2nd, Joseph; Pareek, Gyan et al. (2018) Perioperative Morbidity of Open Versus Minimally Invasive Partial Nephrectomy: A Contemporary Analysis of the National Surgical Quality Improvement Program. J Endourol 32:116-123
Laws, Michael Barton; Michaud, Joanne; Shield, Renee et al. (2018) Comparison of Electronic Health Record-Based and Claims-Based Diabetes Care Quality Measures: Causes of Discrepancies. Health Serv Res 53 Suppl 1:2988-3006
Sharma, Vivekanand; Sarkar, Indra Neil (2018) Identifying natural health product and dietary supplement information within adverse event reporting systems. Pac Symp Biocomput 23:268-279
Zhang, Patrick M; Sarkar, Indra Neil (2018) Exploring the Potential of Direct-To-Consumer Genomic Test Data for Predicting Adverse Drug Events. AMIA Jt Summits Transl Sci Proc 2017:247-256
Sellke, Nicholas; Gordon, Caroline; Lawandy, Isabella et al. (2018) Impaired coronary contraction to phenylephrine after cardioplegic arrest in diabetic patients. J Surg Res 230:80-86
Ollila, Thomas A; Olszewski, Adam J (2018) Radiation therapy in primary testicular lymphoma: does practice match the standard of care? Leuk Lymphoma :1-4
Sharma, Vivekanand; Sarkar, Indra Neil (2018) Identifying Supplement Use Within Clinical Notes: An Applicationof Natural Language Processing. AMIA Jt Summits Transl Sci Proc 2017:196-205
Roydhouse, Jessica K; Gutman, Roee; Keating, Nancy L et al. (2018) Differences between Proxy and Patient Assessments of Cancer Care Experiences and Quality Ratings. Health Serv Res 53:919-943
LeBlanc, Thomas W; Egan, Pamela C; Olszewski, Adam J (2018) Transfusion dependence, use of hospice services, and quality of end-of-life care in leukemia. Blood 132:717-726
Olszewski, Adam J; Ollila, Thomas; Reagan, John L (2018) Time to treatment is an independent prognostic factor in aggressive non-Hodgkin lymphomas. Br J Haematol 181:495-504

Showing the most recent 10 out of 57 publications